Pharma traders protest govt's move to add e-pharmacy links to Aarogya Setu

The organisation today alleged that the NITI Aayog has added links to four e-pharmacy players

Aarogya Setu app, coronavirus, flights
The Organisation has sought the government to de-link the AarogyaSetuMitr from the app
Gireesh Babu Chennai
2 min read Last Updated : May 18 2020 | 2:08 AM IST
The pharma trader's body All India Organisation of Chemists and Druggists (AIOCD) is up in arms against the Central government allegedly promoting e-pharmacy firms through the AarogyaSetuMitr facility offered through its AarogyaSetu mobile application.

The Organisation has sought the government to de-link the AarogyaSetuMitr from the app.

The organisation today alleged that the NITI Aayog has added links to four e-pharmacy players through the www.aarogyasetumitr.in extension of the app, thus promoting the online pharmacies, which it calls as "highly illegal, arbitrary and discriminatory manner as a marketing tool app".

J S Shinde President AIOCD said that its 850,000 members, their families and dependents, numbers run into over 3.5 crore are local, but sidelined while NITI Aayog promoted few Foreign funded entities in contradiction to the Prime Minister's announcement on "support local and be vocal for local". It is not only strange but shall devastate livelihood of local chemists, he added.

"We have been working along with the government all through the lockdown when the normal operations were paralysed putting all our efforts to avoid shortage of drug in any part of the country. And the government is giving a backdoor entry to the online pharmacies now. We are angry over this decision," said Rajiv Singhal, general secretary, AIOCD. AIOCD has also been promoting the AarogyaSetu App to its members and other stakeholders but the online pharmacy links were added almost four to five days back, he said.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :CoronavirusLockdownPharma sectorNITI Ayog

Next Story